The others are the lieutenant governor, attorney general, secretary of state, state treasurer, insurance commissioner and Kansas Supreme Court chief justice and four Republican leaders in the GOP-controlled Legislature. The legislative leaders and the state’s Republican attorney general passed, for now, because not all health care workers and nursing home residents have received theirs. The governor also said Wednesday that “hundreds” of other, non-elected state officials have been made eligible for early vaccines by their agencies. The others are the lieutenant governor, attorney general, secretary of state, state treasurer, insurance commissioner and Kansas Supreme Court chief justice and four Republican leaders in the GOP-controlled Legislature. Most of those Republicans said they didn’t want to jump in line ahead of health care workers, nursing home residents or other vulnerable Kansans.

(AP Photo/Emrah Gurel)BEIJING — Authorities in China’s northeastern port city of Dalian are testing millions of residents after seven new coronavirus cases were reported there in the last 24 hours. It has a deal to secure up to 100 million doses of the potential vaccine produced by AstraZeneca. Koca said the first shipment of three million doses of CoronaVac would be shipped to Turkey on Sunday and arrive Monday. He said Turkey could get 4.5 million doses until the end of March and would have the option buy up to 30 million doses. Indonesia has reported nearly 700,000 COVID-19 cases, the largest caseload in Southeast Asia and second in Asia only to India’s 10.1 million confirmed cases.

DETROIT – As doses of the Pfizer-BioNTech COVID-19 vaccine make their way into the arms of the first recipients, the data the Food and Drug Administration will be using to potentially authorize Moderna’s COVID-19 vaccine was made public. For the Moderna study, two doses of their mRNA vaccine were administered 28 days apart, that’s different than the 21 days between doses of the Pfizer vaccine. Twenty-five percent of those enrolled in the Moderna study were older than 65. That’s similar to the 21 percent in the Pfizer vaccine study who were in that age group. The primary question was how effectively the Moderna vaccine could prevent symptomatic COVID-19 infection 14 days after the second dose of the vaccine.